Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ICCM IceCure Medical Ltd. Ordinary Shares
$3.51 7.01% +0.23
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ICCM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 12.0M
Enterprise value 358.5K
Trailing PE -0.48611111111111
Forward PE -1.2968526
PEG Ratio -0.00016436662516101
Enterprise to EBITDA -0.023
Enterprise to revenue 0.101
Price to book MRQ 1.0369864
Price to sales TTM 3.1285255

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 3.6M
EBITDA -15409000
Diluted EPS TTM -7.2
Total Cash (MRQ) 8.1M
Current ratio (MRQ) 2.524
Operating Cash Flow (TTM) -14807000

ICCM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ICCM News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.